Content by user

Chlorhexidine (Peridex)

Debbie Vigliotti's picture

Forums: 

The mfr that provides Peridex is no longer making the unit dose (UD)cup. We do not know of another mfr that makes UD chlorhexidine. We use upwards of 1100 UD cups per month; we had originally planned on unit dosing it ourselves but cannot possibly keep up with this volume without letting something else go (i.e., not having a triage tech during critical times operationally).

IV Lovenox Concentrations

DiAnthia Patrick's picture

Forums: 

Hello,
Wondering if anyone does IV lovenox at their institution and have information you're willing to share on what concentrations you prepare?
We're a children's hospital and we prepare 20 mG/mL concentration for all IV doses, and for SC doses LESS than 10 mg. We have request from hematology for lower concentrations. While the justification is sound we're struggling with data and even standards of practice in other places.

Thanks.
DiAnthia

PPE for Nurse Administration of Megace Liquid

Holly Trotter's picture

Forums: 

The 2016 NIOSH document on hazardous drugs lists Megace in Group 1. They further indicated that PPE is required for administration of agents in Group 1. If I am reading this correctly, oral liquid formulations require basically the same PPE as that required for the administration of IV Chemotherapy.

How are you translating this into practice? I would like to get rid of Megace completely, but my docs are not on board.

Dextrose 50% 50ml syringes alternatives

Brenda Santiago's picture

Forums: 

How has your institution manage the dextrose 50% 50ml syringe shortage? We are looking into the use of Dextrose 10% IV piggy as an alternative. I found 2 studies but are mostly for emergency medicine.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726850/pdf/v022p00512.pdf

https://www.ncbi.nlm.nih.gov/pubmed/24735872

I would greatly appreciate some insight.

System-level FDA Recall Management

Bryan R Bailey's picture

Forums: 

Greetings,

Does anybody have a system-level policy/process regarding management of recalls for pharmaceuticals, medical equipment/devices, etc they could share? I’m specifically interested in any policies/mechanisms that include requirements for individual facilities to report back to system leadership about recall impact and actions taken in response to a recall (e.g., quantity on hand, quantity unaccounted for, removal of product from stock completed, # of patients affected, level of patient harm, was patient notification necessary, patient notification completed).

Auditing Non-Profiled ADMs

Jim Galasso's picture

Forums: 

Hello,

I was hoping someone could provide information pertaining to the following questions.

1. Do you have any non-profiled Automatic Dispensing Machines (ADMs) in your institution?

If the answer is no, the survey ends here.

2. Do you audit medications pulled from ADMs against orders in non-profiled areas?

If the answer is no, the survey ends here.

Pages